KalVista Pharmaceuticals
Agnes Qerimi currently serves as the Executive Director of Pricing Strategy and Operations at KalVista Pharmaceuticals, Inc., a position held since May 2025. Prior to this role, Agnes held various positions at Alnylam Pharmaceuticals from April 2020 to May 2025, including Head of Strategic Account Management Program, Director, and Senior Director. From August 2011 to April 2020, Agnes worked at Sunovion Pharmaceuticals Inc. as Director of Government Pricing and Compliance and also held the roles of Associate Director and Senior Manager in the same department. Earlier in the career, Agnes was with Hospira as Section Manager and Senior Financial Analyst from January 2006 to August 2011. Agnes earned a Bachelor's degree in Finance from DePaul University, completing studies between 2000 and 2004.
This person is not in any teams
This person is not in any offices
KalVista Pharmaceuticals
2 followers
KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases....